Interventional Neurology Devices & Equipment - Global Market Analysis & Outlook Report, 2015-2030 - ResearchAndMarkets.com

DUBLIN--()--The "Interventional Neurology Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.

Where is the largest and fastest growing market for the interventional neurology devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The global interventional neurology devices and equipment market was valued at about $1.5 billion in 2018 and is expected to grow to $1.51 billion at a CAGR of 0.1% through 2022. Major players in the market are Medtronic, Stryker, Terumo Corporation, Penumbra and Covidien. In 2018, North America was the largest region in the interventional neurology devices and equipment. During the forecast period, Asia Pacific is forecasted to register the highest CAGR.

Increase in the patient population with the neurological disorders is driving the Interventional neurology devices market. Neural disorders like Alzheimer disease, cerebrovascular diseases including stroke, migraine and other headache disorders are on the rise. The rapid increase in the geriatric population, high-stress levels in young individuals and head injuries due to accidents are the main reasons for neural disorders. For example, according to the Brain Aneurysm Foundation, it is estimated that in United States, 6 million people suffer from unruptured brain aneurysm. Also, according to World Health Organization, more than 50 million have epilepsy and over 47 million have dementia. Hence, the rapid increase in the incidence of the neurological disorders is slated to boost the market in the forecast period.

Strict regulatory policies by the US FDA for the approval of Interventional Neurological Devices will hinder the interventional neurological devices market growth. FDA gives approval for the devices based on the class of the devices. Most of the devices under Interventional Neurological Devices are classified under the class 3 devices. Class 3 devices required to undergo a lot of approvals from the regulatory bodies which is a time consuming process. For example, the approval for the class 3 devices may take more than 36 months, thereby increasing the overall cost of product development, impacting the market negatively.

Stryker Inc.'s latest technological development Neuroform Atlas Stent System is expected to provide significant results to treat brain aneurysms with embolic coils. The introduction of such technologies would drive the interventional neurological device market in the future. The Atlas stent system provides great support during the coiling procedures and it has been designed s to provide the coil support and wall apposition needed to perform effective stent-assisted coiling procedure. Neuroform Atlas has enhanced stent conformability, a low-profile delivery system and high deployment accuracy even in distal anatomy makes it the latest choice of the neuro-surgeons, thereby steering the market.

The United States Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) presides over the regulation and approval of medical devices in the USA. Within CDRH, the Division of Neurological and Physical Medicine Devices reviews medical technologies that interface with the central and peripheral nervous system (neurotechnologies), including neurointerventional medical devices that are used in the treatment of stroke. Also, the division of Neurological and Physical Medicine Devices (DNPMD) serves as the primary point of review at the FDA for regulatory submissions involving medical device neurotechnologies.

Although the process of approval is strenuous and the time taken is too long, the devices approved by FDA have had a major impact on the markets and the products approved by FDA are successful. FDA has been actively approving devices in the interventional neurosurgery device division which has boosted the market's growth. For example, approval of Stryker's Neuroform Atlas Stent System, De Novo clearance for Nerivio Migra and Pipeline Flex embolization by Medtronic are the recent approvals made by FDA which enhances the market's growth.

Key Topics Covered

1. Executive Summary

2. Interventional Neurology Devices And Equipment Market Characteristics

3. Interventional Neurology Devices And Equipment Market Size And Growth

3.1. Global Interventional Neurology Devices And Equipment Historic Market, 2015 - 2019, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Interventional Neurology Devices And Equipment Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Interventional Neurology Devices And Equipment Market Segmentation

4.1. Global Interventional Neurology Devices And Equipment Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • Aneurysm Coiling & Embolization Devices
  • Cerebrospinal Fluid Management Devices
  • Neurothrombectomy Devices
  • Support Devices

4.2. Global Interventional Neurology Devices And Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • Hospitals Neurology Clinics
  • Ambulatory Care Centers
  • Others

4.3. Global Interventional Neurology Devices And Equipment Market, Segmentation Aneurysm Coiling & Embolization Devices By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • Embolic Coils
  • Flow Diversion Devices
  • Liquid Embolic Devices

4.4. Global Interventional Neurology Devices And Equipment Market, Segmentation Angioplasty Devices by Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • Carotid artery stents
  • Embolic protection systems

4.5. Global Interventional Neurology Devices And Equipment Market, Segmentation Support Devices By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • Micro guide wires
  • Micro catheters

4.6. Global Interventional Neurology Devices And Equipment Market, Segmentation Neurothrombectomy Devices By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • CLOT retrieval devices
  • Suction and aspiration devices
  • Snares

5. Interventional Neurology Devices And Equipment Market Regional And Country Analysis

5.1. Global Interventional Neurology Devices And Equipment Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

5.2. Global Interventional Neurology Devices And Equipment Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

Companies Mentioned

  • Abbott
  • Acandis
  • Bayer AG
  • Biosensors International
  • Boston Scientific Corporation
  • COOK Medicals
  • Covidien
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services Inc.
  • Magstim C-Ltd.
  • Medikit Co. Ltd.
  • Medtronic
  • Merit Medical Systems
  • MicroPort Scientific Corporation
  • Penumbra
  • Sequent Medical
  • St. Jude Medical
  • Stryker
  • Terumo Corporation
  • UreSil LLC
  • W. L. Gore & Associates

For more information about this report visit https://www.researchandmarkets.com/r/n2tnuu

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900